PTGX vs RIDE
Protagonist Therapeutics Inc (PTGX) versus RIDE (RIDE) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
RIDE (RIDE) common stock.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
RIDE does not have a complete income-statement cache yet.
PTGX currently screens at market cap $7.25B.
Not investment advice. Open the PTGX and RIDE stock pages for the full models.
Not investment advice.